Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancer
Roman Perez-Soler
Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
99
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Erlotinib Hydrochloride
100%
Non-Small Cell Lung Carcinoma
70%
ErbB Receptors
56%
Survival
43%
Exanthema
39%
Appointments and Schedules
32%
Maximum Tolerated Dose
23%
Platinum
20%
Combination Drug Therapy
19%
Protein-Tyrosine Kinases
17%
Patient Selection
17%
Carcinoma
13%
Therapeutics
12%
Drug Therapy
11%